Converging or Crossing Curves: Untie the Gordian Knot or Cut it? Appropriate Statistics for Non-Proportional Hazards in Decitabine DACO-016 Study (AML)Jörg Tomeczkowski, Christoph Tapprich, Ansgar Lange et al.|Advances in Therapy|2015Cited by 11
Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany: An Analysis of Sickness FundsJörg Tomeczkowski, Christoph Tapprich, C. Khuen et al.|Value in Health|2014Cited by 4
Analyses Adjusting for Selective Crossover Show Improved Overall Survival with Decitabine Compared with Treatment Choice in DACO-016 Phase III TrialJörg Tomeczkowski, Christoph Tapprich, Joris Diels et al.|Value in Health|2013Cited by 0
PCN27 Analysis of Prevalence and Treatment of Multiple Myeloma in German Statutory Sick Funds Claim DataJörg Tomeczkowski, Wolfgang Knauf, Daniel Wirth et al.|Value in Health|2012Cited by 0
PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in GermanyJörg Tomeczkowski, Christoph Tapprich, Ulrike Theidel et al.|Value in Health|2012Cited by 0